abinvivo

Top biotechs choose Biointron to accelerate antibody production. Our CRO expertise ensures speed, reliability, and global delivery of antibody solutions.

Trastuzumab revolutionized breast cancer therapy as the first HER2-targeting antibody. Biointron reviews its approval and enduring impact on oncology.

Partner with Biointron for antibody discovery. Our CRO expertise delivers custom antibodies and scalable solutions that accelerate therapeutic development.

High-purity antibodies are vital for reliable research. Biointron emphasizes quality control to prevent misleading results and accelerate discoveries.

In vivo antibody testing validates therapies. Biointron highlights methods to evaluate efficacy and safety before clinical application.

Microtubule inhibitors power certain ADCs. Biointron highlights how these payloads, combined with antibodies, deliver targeted cancer therapies.

Rituximab marked a milestone as the first cancer antibody. Biointron reviews its approval, clinical use, and role in shaping oncology therapeutics.

Infliximab was the first antibody for IBD. Biointron reviews its approval, mechanism, and impact on advancing therapeutic monoclonal antibodies.

Abinvivo delivers in vivo antibody products for research and development. Biointron showcases their differentiation, applications, and benefits for discovery programs.

ADCs have evolved into powerful cancer drugs. Biointron reviews their history, design improvements, and future directions in targeted therapy.

DAR is key to ADC success. Biointron explains how drug-to-antibody ratios shape potency, safety, and outcomes in cancer therapy.

Bispecific antibodies fight cancer via unique mechanisms. Biointron highlights how bsAbs target multiple pathways to expand therapeutic impact.

Anti-mouse antibodies remain vital research tools. Biointron delivers reliable anti-mouse antibodies that support validation and consistent experimental results.

Isotype negative antibodies are essential controls. Biointron outlines their role in research, ensuring reliable data and validating experimental outcomes.

Benchmark Positive Antibodies ensure reliable validation. Biointron explains their role in confirming assay accuracy and building trust in experimental results.